BDNF and Huntington disease: Another study identified an increase in BDNF promoter methylation observed in the blood of HD mutation carriers (pre‐symptomatic and symptomatic), which correlated with psychiatric symptoms in HD, suggesting that it may be relevant as a biomarker in HD [125].